RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/17446348http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/17446348http://www.w3.org/2000/01/rdf-schema#comment"In acute myeloid leukemia (AML), mutational activation of the receptor tyrosine kinase (RTK) Flt3 is frequently involved in leukemic transformation. However, little is known about a possible role of highly expressed wild-type Flt3 in AML. The proto-oncogene c-Cbl is an important regulator of RTK signaling, acting through its ubiquitin ligase activity and as a platform for several signaling adaptor molecules. Here, we analyzed the role of c-Cbl in Flt3 signal transduction and myeloid transformation. C-Cbl physically interacted with Flt3 and was tyrosine phosphorylated in the presence of Flt3-ligand (FL). Overexpression of a dominant-negative form of c-Cbl (Cbl-70Z) inhibited FL-induced Flt3 ubiquitylation and internalization, indicating involvement of c-Cbl in Flt3 signaling. DNA sequencing of AML bone marrow revealed a case with a c-Cbl point mutation (Cbl-R420Q). Cbl-R420Q inhibited Flt3 internalization and ubiquitylation. Coexpression of Cbl-R420Q or Cbl-70Z with Flt3 induced cytokine-independent growth and survival of 32Dcl3 cells in the absence of FL. Also, the mutant Cbl proteins altered the amplitude and duration of Flt3-dependent signaling events. Our results indicate an important role of Cbl proteins in Flt3 signal modulation. Also, the data suggest a novel mechanism of leukemic transformation in AML by mutational inactivation of negative RTK regulators."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.org/dc/terms/identifier"doi:10.1182/blood-2007-01-066076"xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Choudhary C."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Duyster J."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Dikic I."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Berdel W.E."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Muller-Tidow C."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Sargin B."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Schwable J."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Serve H."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Koschmieder S."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Tickenbrock L."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Crosetto N."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Grundler R."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"August B."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Brandts C."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Schmidt M.H.H."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Bandi S.R."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Rensinghoff M."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/author"Thiessen C."xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/date"2007"xsd:gYear
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/pages"1004-1012"xsd:string
http://purl.uniprot.org/citations/17446348http://purl.uniprot.org/core/title"Flt3-dependent transformation by inactivating c-Cbl mutations in AML."xsd:string